APA (7th ed.) Citation

Jarraya, B., Lepetit, H., Ralph, S., Boulet, S., Jan, C., Bonvento, G., . . . Palfl, S. (2009). P2.205 A phase I/II clinical trial to evaluate the safety and efflcacy of ProSavin®, a gene therapy approach for Parkinson's disease. Parkinsonism & Related Disorders, 15, S145. https://doi.org/10.1016/S1353-8020(09)70556-5

Chicago Style (17th ed.) Citation

Jarraya, B., et al. "P2.205 A Phase I/II Clinical Trial to Evaluate the Safety and Efflcacy of ProSavin®, a Gene Therapy Approach for Parkinson's Disease." Parkinsonism & Related Disorders 15 (2009): S145. https://doi.org/10.1016/S1353-8020(09)70556-5.

MLA (9th ed.) Citation

Jarraya, B., et al. "P2.205 A Phase I/II Clinical Trial to Evaluate the Safety and Efflcacy of ProSavin®, a Gene Therapy Approach for Parkinson's Disease." Parkinsonism & Related Disorders, vol. 15, 2009, p. S145, https://doi.org/10.1016/S1353-8020(09)70556-5.